Frequently Asked Questions
Quick answers to common questions about stem cell therapy, safety standards, and care in Malaysia.
Frequently Asked Questions?
About Stem Cell Therapy
What is Mesenchymal Stem Cell (MSC) therapy?
MSC therapy refers to treatments and wellness approaches—such as stem cell infusions—that utilize mesenchymal stem cells (MSCs). A key characteristic of MSCs used for intravenous administration is their low immunogenicity, meaning they tend to trigger less immune response compared with immune cells like leukocytes or lymphocytes. For this reason, MSCs may be used not only as autologous cells (from the patient) but also as allogeneic cells (from a donor) in many settings.
Because MSCs are generally considered less likely to provoke strong immune reactions, they are often regarded as having a lower risk of rejection. In Malaysia, umbilical cord–derived MSCs are commonly used in practice, and there are clinical cases where they have been administered across diverse patient backgrounds, regardless of the donor’s ethnicity.
Note: Safety and suitability also depend on factors such as manufacturing standards, quality control, and testing protocols. It is advisable to confirm the clinic’s procedures and explanations before proceeding.
Because MSCs are generally considered less likely to provoke strong immune reactions, they are often regarded as having a lower risk of rejection. In Malaysia, umbilical cord–derived MSCs are commonly used in practice, and there are clinical cases where they have been administered across diverse patient backgrounds, regardless of the donor’s ethnicity.
Note: Safety and suitability also depend on factors such as manufacturing standards, quality control, and testing protocols. It is advisable to confirm the clinic’s procedures and explanations before proceeding.
What conditions can MSCs help with?
Stem cell infusions are sometimes considered as an approach to support the body’s recovery environment by influencing inflammation and tissue stress through cell-to-cell signaling and secreted factors associated with stem cells. They are often discussed in the context of overall wellness and aging support, and people may inquire about them for purposes such as:
・Maintaining skin and beauty-related condition
・Supporting general health and reducing feelings of fatigue
・Potentially influencing immune and inflammatory balance
・Considering them as an adjunct option for chronic concerns, depending on the case
If the main goal is symptom improvement for a specific medical condition, it is important not to proceed based on self-judgment. Instead, patients should consult a qualified physician, ideally by sharing relevant information such as a primary doctor’s assessment and health screening results, to discuss suitability, realistic expectations, risks, and alternatives. Where appropriate, a specialist in Malaysia may also provide medical input based on the submitted clinical information.
・Maintaining skin and beauty-related condition
・Supporting general health and reducing feelings of fatigue
・Potentially influencing immune and inflammatory balance
・Considering them as an adjunct option for chronic concerns, depending on the case
If the main goal is symptom improvement for a specific medical condition, it is important not to proceed based on self-judgment. Instead, patients should consult a qualified physician, ideally by sharing relevant information such as a primary doctor’s assessment and health screening results, to discuss suitability, realistic expectations, risks, and alternatives. Where appropriate, a specialist in Malaysia may also provide medical input based on the submitted clinical information.
After a stem cell infusion, where do the cells go, and how do they work?
After intravenous administration, mesenchymal stem cells (MSCs) circulate through the bloodstream. Rather than remaining randomly throughout the body, MSCs are often described as having a tendency to move toward areas where inflammation or tissue injury is present. This behavior is commonly referred to as “homing.”
▼ How homing is generally explained
・In inflamed or damaged tissues, chemical signals such as cytokines and chemokines may increase.
・MSCs are thought to respond to these signals while circulating and may migrate toward the affected area.
・Once near the target tissue, MSCs are believed to support recovery processes by releasing bioactive factors that can influence inflammatory balance and tissue repair pathways.
▼ A simplified flow
1. Enter the bloodstream via infusion
2. Circulate systemically
3. Tend to accumulate toward areas with elevated injury/inflammation signals
4. In some cases, move across the vessel wall toward tissue proximity
5. Release factors that support local cellular functions related to repair and inflammatory modulation
▼ How homing is generally explained
・In inflamed or damaged tissues, chemical signals such as cytokines and chemokines may increase.
・MSCs are thought to respond to these signals while circulating and may migrate toward the affected area.
・Once near the target tissue, MSCs are believed to support recovery processes by releasing bioactive factors that can influence inflammatory balance and tissue repair pathways.
▼ A simplified flow
1. Enter the bloodstream via infusion
2. Circulate systemically
3. Tend to accumulate toward areas with elevated injury/inflammation signals
4. In some cases, move across the vessel wall toward tissue proximity
5. Release factors that support local cellular functions related to repair and inflammatory modulation
Why is allogeneic (donor-derived) cell therapy often said to be more effective than autologous (self-derived) cell therapy?
Fist, it cannot be definitively stated that allogeneic (donor-derived) cells are always superior to autologous (self-derived) cells. Outcomes may vary depending on the disease area, administration design, cell specifications, and manufacturing quality.
That said, the following points are commonly cited as reasons why allogeneic cell culture is often selected.
1. Cell condition (less affected by aging)
It is now understood that cells are also influenced by age.
Autologous MSCs are known to be more susceptible to reduced proliferative capacity and immunomodulatory function due to factors such as the patient’s age, inflammatory status, lifestyle, and underlying conditions.
In contrast, MSCs derived from younger tissues such as the umbilical cord are among the youngest and healthiest stem cells available, and are generally expected to have advantages in terms of cell proliferation and functional performance.
2. Easier standardization of manufacturing and quality control
Allogeneic culture offers practical advantages in that donor-derived cells—selected and tested according to defined criteria—can be cultured in a planned manner, making it easier to standardize processes, testing, and specifications.
As a result, it becomes easier to design operations related to cell counts, test items, and shipment release decisions, contributing to greater consistency in the quality of the provided cells.
3. Reduced physical burden by eliminating the need for cell harvesting
Autologous culture may require procedures such as fat tissue harvesting, which can involve surgical burden and scheduling considerations.
With allogeneic culture, no such harvesting procedure is required, making it a preferred option from the standpoint of both physical burden and overall treatment logistics.
4. Expectations regarding homing function
Stem cells possess a “homing function,” which refers to their ability to migrate toward sites of injury within the body.
This function is believed to be more pronounced in younger stem cells, and therefore may contribute to greater functional potential.
At our company, we handle stem cells derived from umbilical cord Wharton’s Jelly.
Throughout the entire process—from donor selection and cell culturing facilities to administration—we place the highest priority on safety and guide our clients accordingly.
That said, the following points are commonly cited as reasons why allogeneic cell culture is often selected.
1. Cell condition (less affected by aging)
It is now understood that cells are also influenced by age.
Autologous MSCs are known to be more susceptible to reduced proliferative capacity and immunomodulatory function due to factors such as the patient’s age, inflammatory status, lifestyle, and underlying conditions.
In contrast, MSCs derived from younger tissues such as the umbilical cord are among the youngest and healthiest stem cells available, and are generally expected to have advantages in terms of cell proliferation and functional performance.
2. Easier standardization of manufacturing and quality control
Allogeneic culture offers practical advantages in that donor-derived cells—selected and tested according to defined criteria—can be cultured in a planned manner, making it easier to standardize processes, testing, and specifications.
As a result, it becomes easier to design operations related to cell counts, test items, and shipment release decisions, contributing to greater consistency in the quality of the provided cells.
3. Reduced physical burden by eliminating the need for cell harvesting
Autologous culture may require procedures such as fat tissue harvesting, which can involve surgical burden and scheduling considerations.
With allogeneic culture, no such harvesting procedure is required, making it a preferred option from the standpoint of both physical burden and overall treatment logistics.
4. Expectations regarding homing function
Stem cells possess a “homing function,” which refers to their ability to migrate toward sites of injury within the body.
This function is believed to be more pronounced in younger stem cells, and therefore may contribute to greater functional potential.
At our company, we handle stem cells derived from umbilical cord Wharton’s Jelly.
Throughout the entire process—from donor selection and cell culturing facilities to administration—we place the highest priority on safety and guide our clients accordingly.
Safety & Regulations
Is MSC therapy legal in Malaysia?
Yes. In Malaysia, strict regulations and oversight are applied to every process involved in stem cell therapy.
Pharmaceutical companies that culture stem cells, as well as hospitals and clinics that provide the treatment, are required to submit the necessary information to the Ministry of Health (MOH) Malaysia and pass various inspections and reviews.
Specifically, the following aspects are examined:
・The appropriateness of the stem cell culturing environment and methods
・The quality and viability of the stem cells
・The condition of packaging and the suitability of the transportation environment at the time of shipment
・Verification that there are no issues with the health status or genetic background of the stem cell donors (mother and child)
Only after meeting all of these standards are providers permitted to offer stem cell therapy, allowing patients to receive treatment with confidence.
Pharmaceutical companies that culture stem cells, as well as hospitals and clinics that provide the treatment, are required to submit the necessary information to the Ministry of Health (MOH) Malaysia and pass various inspections and reviews.
Specifically, the following aspects are examined:
・The appropriateness of the stem cell culturing environment and methods
・The quality and viability of the stem cells
・The condition of packaging and the suitability of the transportation environment at the time of shipment
・Verification that there are no issues with the health status or genetic background of the stem cell donors (mother and child)
Only after meeting all of these standards are providers permitted to offer stem cell therapy, allowing patients to receive treatment with confidence.
What risks should I be aware of?
When considering stem cell IV therapy (infusion using cells that include MSCs), the risks can broadly be categorized into the following three areas.
1. General risks associated with medical procedures
・Temporary physical reactions related to the infusion (such as fever, chills, fatigue, or headache)
・Pain, swelling, or bruising at the infusion site
・Depending on individual constitution, there is a possibility of allergy-like reactions
2. Cases where treatment is not recommended or requires careful consideration due to health status or medical history
The following are representative examples.
Whether treatment is appropriate is determined by a physician based on an overall medical assessment.
・Ongoing or active cancer, or currently undergoing cancer treatment
・Severe immunodeficiency (e.g., HIV infection or strong immunosuppressive conditions)
・Serious infections or unexplained fever (infection control should be prioritized first)
・Severe liver or kidney failure where overall physical condition is unstable
・Patients undergoing dialysis (as safety and efficacy data are often limited, some facilities may exclude such cases or apply particularly cautious criteria)
Based on our physicians’ assessment, individuals who fall under the above categories are generally advised to refrain from stem cell therapy.
While there are some studies reporting effectiveness in cancer-related cases, our position is that there are still many unknown risks. Therefore, we do not provide stem cell therapy for cancer at this time.
3. Risks related to the provision system (quality control and regulatory compliance)
In the field of cellular and regenerative medicine, there have been reported cases of serious health issues (such as infections) linked to unapproved or inappropriate treatments, particularly where sterile control or quality management was insufficient.
For this reason, it is important to confirm where and under what standards the cells are processed, how they are tested, and how shipment approval is determined.
▼ Our approach (what we prioritize for safety)
Rather than making definitive claims about efficacy, we place the highest priority on safety and transparency of procedures.
Specifically, we carefully assess in advance whether a patient falls under any categories requiring cautious consideration, and when necessary, we connect this process to a physician’s judgment based on information from the patient’s primary doctor or relevant medical test data.
We also strive to explain our quality control, testing, and management systems within the scope that can be disclosed, so that patients can review the treatment with confidence and clarity before making a decision.
1. General risks associated with medical procedures
・Temporary physical reactions related to the infusion (such as fever, chills, fatigue, or headache)
・Pain, swelling, or bruising at the infusion site
・Depending on individual constitution, there is a possibility of allergy-like reactions
2. Cases where treatment is not recommended or requires careful consideration due to health status or medical history
The following are representative examples.
Whether treatment is appropriate is determined by a physician based on an overall medical assessment.
・Ongoing or active cancer, or currently undergoing cancer treatment
・Severe immunodeficiency (e.g., HIV infection or strong immunosuppressive conditions)
・Serious infections or unexplained fever (infection control should be prioritized first)
・Severe liver or kidney failure where overall physical condition is unstable
・Patients undergoing dialysis (as safety and efficacy data are often limited, some facilities may exclude such cases or apply particularly cautious criteria)
Based on our physicians’ assessment, individuals who fall under the above categories are generally advised to refrain from stem cell therapy.
While there are some studies reporting effectiveness in cancer-related cases, our position is that there are still many unknown risks. Therefore, we do not provide stem cell therapy for cancer at this time.
3. Risks related to the provision system (quality control and regulatory compliance)
In the field of cellular and regenerative medicine, there have been reported cases of serious health issues (such as infections) linked to unapproved or inappropriate treatments, particularly where sterile control or quality management was insufficient.
For this reason, it is important to confirm where and under what standards the cells are processed, how they are tested, and how shipment approval is determined.
▼ Our approach (what we prioritize for safety)
Rather than making definitive claims about efficacy, we place the highest priority on safety and transparency of procedures.
Specifically, we carefully assess in advance whether a patient falls under any categories requiring cautious consideration, and when necessary, we connect this process to a physician’s judgment based on information from the patient’s primary doctor or relevant medical test data.
We also strive to explain our quality control, testing, and management systems within the scope that can be disclosed, so that patients can review the treatment with confidence and clarity before making a decision.
Is MSC therapy safe? What side effects may occur?
Stem cell IV therapy (MSC-based infusion) has been reported in many clinical studies to be relatively well tolerated (meaning it can be received by a wide range of patients). However, as it is a medical procedure, this does not mean that reactions are entirely absent. The most commonly reported effects are transient reactions associated with the infusion itself.
▼ Examples of commonly reported temporary reactions
・Fever, chills, or a sensation of warmth (often reported to subside on the same day or shortly after the infusion)
・Fatigue, headache, or dizziness
・Pain, swelling, or bruising at the infusion site
▼ Points requiring attention
・If symptoms are severe or prolonged, medical evaluation by a physician is necessary to determine whether they are related to the infusion or due to other causes.
・Historically, serious health issues related to stem cell therapies have been associated with unapproved or inappropriate treatments, particularly where sterile control, manufacturing standards, or quality management were insufficient. For this reason, it is important to confirm the management and quality control system of the provider.
・International guidelines also strongly emphasize that stem cell therapies should be provided only under appropriate scientific evidence, regulatory oversight, and informed consent.
▼ Our approach (points we would like to share for reassurance)
Rather than making definitive claims about efficacy, we place the highest priority on safety and the reliability of our processes.
Specifically, we emphasize operations with multiple checkpoints, including donor and source material screening, testing before and after cell culture, inspections prior to shipment, and ensuring full traceability.
In addition, we do not use cryopreserved (frozen) stem cells. After the completion of cell culture and all required testing, we provide the cells in a fresh state.
This approach helps prevent the inclusion of dead cells or impurities and allows us to offer stem cells in a condition where both safety and potential effectiveness can be better expected.
At the time of administration, we proceed on the premise of a pre-treatment medical consultation and confirmation, as well as continuous monitoring during infusion, with appropriate response systems in place if needed.
(Note: Final decisions regarding suitability and risk assessment are made by the attending physician.)
▼ Examples of commonly reported temporary reactions
・Fever, chills, or a sensation of warmth (often reported to subside on the same day or shortly after the infusion)
・Fatigue, headache, or dizziness
・Pain, swelling, or bruising at the infusion site
▼ Points requiring attention
・If symptoms are severe or prolonged, medical evaluation by a physician is necessary to determine whether they are related to the infusion or due to other causes.
・Historically, serious health issues related to stem cell therapies have been associated with unapproved or inappropriate treatments, particularly where sterile control, manufacturing standards, or quality management were insufficient. For this reason, it is important to confirm the management and quality control system of the provider.
・International guidelines also strongly emphasize that stem cell therapies should be provided only under appropriate scientific evidence, regulatory oversight, and informed consent.
▼ Our approach (points we would like to share for reassurance)
Rather than making definitive claims about efficacy, we place the highest priority on safety and the reliability of our processes.
Specifically, we emphasize operations with multiple checkpoints, including donor and source material screening, testing before and after cell culture, inspections prior to shipment, and ensuring full traceability.
In addition, we do not use cryopreserved (frozen) stem cells. After the completion of cell culture and all required testing, we provide the cells in a fresh state.
This approach helps prevent the inclusion of dead cells or impurities and allows us to offer stem cells in a condition where both safety and potential effectiveness can be better expected.
At the time of administration, we proceed on the premise of a pre-treatment medical consultation and confirmation, as well as continuous monitoring during infusion, with appropriate response systems in place if needed.
(Note: Final decisions regarding suitability and risk assessment are made by the attending physician.)
Where do the stem cells come from?
In many cases, they are sourced from umbilical cords collected after childbirth through consent-based, ethical donation. Donors typically undergo medical screening, and the material is then processed and manufactured under strict quality and hygiene controls, often within GMP-compliant systems or GMP-certified facilities.
Are the donors healthy?
Yes. For umbilical cord–derived stem cell products, it is standard practice to assess the donors (mother and baby) to ensure there are no major health concerns and to reduce risks such as infectious diseases through appropriate screening.
At our company, safety is treated as the top priority, and we set multiple checkpoints throughout the supply and manufacturing process. These checks are used to inform the final release decision. Typical checkpoints include:
・Donor health screening
・Verification that the collected umbilical cord tissue shows no signs of infection-related concerns
・Testing of cell samples collected before culture
・Final testing after culture is completed, immediately prior to release/shipment from the laboratory
At our company, safety is treated as the top priority, and we set multiple checkpoints throughout the supply and manufacturing process. These checks are used to inform the final release decision. Typical checkpoints include:
・Donor health screening
・Verification that the collected umbilical cord tissue shows no signs of infection-related concerns
・Testing of cell samples collected before culture
・Final testing after culture is completed, immediately prior to release/shipment from the laboratory
What is GMP?
GMP stands for Good Manufacturing Practice. It is a quality and manufacturing management framework used for products such as pharmaceuticals and cell-based products. The key idea is to ensure safety and sterility consistently—not by chance, but through defined procedures, controlled environments, and thorough documentation.
▼ Common elements emphasized under GMP include:
・Facility and hygiene controls designed to reduce contamination risk
・Standard operating procedures (SOPs), with work performed according to them and fully documented
・Traceability from source materials through to final release
・Quality testing and a release decision process based on predefined specifications
・Staff training, equipment maintenance, and structured handling of deviations
▼ Common elements emphasized under GMP include:
・Facility and hygiene controls designed to reduce contamination risk
・Standard operating procedures (SOPs), with work performed according to them and fully documented
・Traceability from source materials through to final release
・Quality testing and a release decision process based on predefined specifications
・Staff training, equipment maintenance, and structured handling of deviations
Treatment Process
What will be covered during the online pre-treatment consultation/counseling?
During the consultation, our goal is to organize which plan may be realistically suitable for you based on your objectives and current health condition, so that you can consider your options with clarity and confidence.
It is completely fine if you are still undecided at this stage, and we encourage you to raise any questions or concerns during the session.
Example topics covered on the day
・Confirmation of your objectives (such as aesthetic concerns, general health maintenance, fatigue, or ongoing issues)
・Review of your health condition, medical history, and current medications
(including checks for conditions that may require careful consideration)
・Explanation of stem cells, from the basics to the specific stem cells we provide
・Overview of how to think about the available plans and options (including general guidelines on dosage, number of sessions, and expected schedule)
・Explanation of the process on the day of treatment and important precautions
・Q&A session to ensure no concerns or uncertainties remain
You’re welcome to reach out to us even if you’re still in the decision-making stage.
Please feel free to contact us via the contact form.
It is completely fine if you are still undecided at this stage, and we encourage you to raise any questions or concerns during the session.
Example topics covered on the day
・Confirmation of your objectives (such as aesthetic concerns, general health maintenance, fatigue, or ongoing issues)
・Review of your health condition, medical history, and current medications
(including checks for conditions that may require careful consideration)
・Explanation of stem cells, from the basics to the specific stem cells we provide
・Overview of how to think about the available plans and options (including general guidelines on dosage, number of sessions, and expected schedule)
・Explanation of the process on the day of treatment and important precautions
・Q&A session to ensure no concerns or uncertainties remain
You’re welcome to reach out to us even if you’re still in the decision-making stage.
Please feel free to contact us via the contact form.
How long does it take?
The infusion itself typically takes about 30 to 60 minutes.
Depending on the clinic’s process and your condition on the day, additional time may be needed for pre-infusion checks, preparation, and brief observation afterward, so the total visit time can vary.
Depending on the clinic’s process and your condition on the day, additional time may be needed for pre-infusion checks, preparation, and brief observation afterward, so the total visit time can vary.
Is it painful?
In most cases, the experience is not significantly different from a standard IV drip.
What you may mainly notice is a brief pinching sensation when the needle is inserted, or mild discomfort during the infusion.
Depending on the individual, factors such as vein condition, tension, or physical sensitivity may cause pain, swelling, or bruising at the insertion site.
For this reason, during the procedure we carefully monitor the condition and adjust the needle position as needed. We also make efforts to create a calm and relaxed environment, including managing room temperature and providing blankets when appropriate.
What you may mainly notice is a brief pinching sensation when the needle is inserted, or mild discomfort during the infusion.
Depending on the individual, factors such as vein condition, tension, or physical sensitivity may cause pain, swelling, or bruising at the insertion site.
For this reason, during the procedure we carefully monitor the condition and adjust the needle position as needed. We also make efforts to create a calm and relaxed environment, including managing room temperature and providing blankets when appropriate.
What happens after treatment?
We recommend avoiding physical strain and strong stimulation and spending your time as calmly as possible from the day of treatment through approximately 48 hours before and after the procedure.
Specifically, please refrain from the following activities.
▼ Activities to avoid (guideline: on the day of treatment and up to 48 hours before and after)
・Alcohol consumption and smoking
・High-intensity exercise that significantly raises body temperature
（such as strength training or running）
・Sauna use or prolonged hot baths
（including soaking in very hot water）
Light activities such as short walks (e.g., shopping) or low-intensity stretching are generally fine, as long as they do not place excessive strain on the body.
▼ Recommended ways to spend your time
After the infusion, some people may temporarily feel fatigue or sluggishness.
・Stay well hydrated by drinking fluids regularly
・Be mindful of maintaining a balanced diet
・Ensure you get adequate sleep
These self-care practices help support your post-infusion condition and provide an important foundation for allowing the stem cells to function effectively as your body uses its energy.
Specifically, please refrain from the following activities.
▼ Activities to avoid (guideline: on the day of treatment and up to 48 hours before and after)
・Alcohol consumption and smoking
・High-intensity exercise that significantly raises body temperature
（such as strength training or running）
・Sauna use or prolonged hot baths
（including soaking in very hot water）
Light activities such as short walks (e.g., shopping) or low-intensity stretching are generally fine, as long as they do not place excessive strain on the body.
▼ Recommended ways to spend your time
After the infusion, some people may temporarily feel fatigue or sluggishness.
・Stay well hydrated by drinking fluids regularly
・Be mindful of maintaining a balanced diet
・Ensure you get adequate sleep
These self-care practices help support your post-infusion condition and provide an important foundation for allowing the stem cells to function effectively as your body uses its energy.
If I choose to continue after the first session, how often is recommended?
As a general guideline, some people consider receiving treatment about once a year.
However, the appropriate interval can vary depending on how you feel after the infusion, how changes appear, your lifestyle, age, and purpose (whether for general health maintenance or support for specific concerns).
▼ Key points
・If your condition is stable and you are not experiencing difficulties in daily life, there is no need to increase the frequency unnecessarily.
・On the other hand, if you start to feel that you are “getting tired more easily than before” or that your overall condition has declined, it is also realistic to revisit the option and consider it again through consultation.
・Even when continuing on a regular basis, it is important to adjust the interval in line with a physician’s judgment, based on ongoing health checks and risk assessments.
At our company, we do not recommend a fixed number of sessions uniformly.
Instead, after confirming your physical condition and lifestyle changes following the first treatment, we assess whether there is a strong need before making a proposal for the next session.
If you wish, we can work together to design sustainable options while taking the physician’s perspective into account.
However, the appropriate interval can vary depending on how you feel after the infusion, how changes appear, your lifestyle, age, and purpose (whether for general health maintenance or support for specific concerns).
▼ Key points
・If your condition is stable and you are not experiencing difficulties in daily life, there is no need to increase the frequency unnecessarily.
・On the other hand, if you start to feel that you are “getting tired more easily than before” or that your overall condition has declined, it is also realistic to revisit the option and consider it again through consultation.
・Even when continuing on a regular basis, it is important to adjust the interval in line with a physician’s judgment, based on ongoing health checks and risk assessments.
At our company, we do not recommend a fixed number of sessions uniformly.
Instead, after confirming your physical condition and lifestyle changes following the first treatment, we assess whether there is a strong need before making a proposal for the next session.
If you wish, we can work together to design sustainable options while taking the physician’s perspective into account.
Programs & Pricing
What is the cost of Stem Cell Treatment
In stem cell IV therapy, pricing tends to reflect factors such as the quality management standards applied, the specifications of the cells used, and the procedures through which they are provided.
▼ Factors that commonly influence pricing
・The origin of the cells (e.g., umbilical cord) and donor-related screening systems
・Standards for culturing and manufacturing management
（such as GMP compliance, testing processes, and traceability）
・Cell count (dosage), number of sessions, and administration design
・Storage and management methods
（temperature control and shipment release decision processes）
・Transportation and delivery conditions
（packaging, temperature range, transit time, and availability of emergency response）
At our company, we do not encourage comparisons based solely on whether a plan is “expensive” or “cheap.”
Instead, we propose plans based on your goals and health condition through careful consultation.
Rather than pushing higher-priced options, we aim to present choices that feel reasonable and well understood. Please feel free to reach out to us for consultation.
▼ Factors that commonly influence pricing
・The origin of the cells (e.g., umbilical cord) and donor-related screening systems
・Standards for culturing and manufacturing management
（such as GMP compliance, testing processes, and traceability）
・Cell count (dosage), number of sessions, and administration design
・Storage and management methods
（temperature control and shipment release decision processes）
・Transportation and delivery conditions
（packaging, temperature range, transit time, and availability of emergency response）
At our company, we do not encourage comparisons based solely on whether a plan is “expensive” or “cheap.”
Instead, we propose plans based on your goals and health condition through careful consultation.
Rather than pushing higher-priced options, we aim to present choices that feel reasonable and well understood. Please feel free to reach out to us for consultation.
How do I get started?
The first step is simply to reach out to us via WhatsApp or through our website inquiry form. We will ask a few brief questions about your goals and current situation, then guide you through the next steps—such as consultation scheduling, any information that may be helpful to prepare, and what to expect in the process.
Helpful (optional) details to share when contacting us
・Your primary goal (wellness, beauty, fatigue, specific concerns, etc.)
・Your current condition, medical history, and medications (as available)
・Whether you have recent health screening results
・Your preferred timing or travel schedule (if applicable)
We do not push treatment decisions at the first contact. Instead, we prioritize safety checks and clear information so you can proceed comfortably and confidently.
Helpful (optional) details to share when contacting us
・Your primary goal (wellness, beauty, fatigue, specific concerns, etc.)
・Your current condition, medical history, and medications (as available)
・Whether you have recent health screening results
・Your preferred timing or travel schedule (if applicable)
We do not push treatment decisions at the first contact. Instead, we prioritize safety checks and clear information so you can proceed comfortably and confidently.
Do you provide on-the-ground support locally?
Yes. Since overseas treatment can raise concerns about travel logistics and language barriers, we have established a support system to ensure that you can feel comfortable even when visiting Malaysia for the first time.
▼ Support services
・Transportation support
（such as transfers between the airport and hotel, and between the hotel and clinic）
- Private vehicles such as Toyota Alphard are typically arranged.
・Interpreter arrangement
- If explanations are needed in languages other than English, interpreters can be arranged depending on the situation.
・Local point of contact
- We provide a local contact point to assist with questions or unexpected concerns during your stay
(the scope of support may vary depending on the situation).
・Basic lifestyle support
- We also provide information to help make your stay smoother, such as nearby dining options and transportation advice.
▼ Important notes
・Airline tickets and hotel reservations are to be arranged by the client.
・The scope of support
（such as service hours, emergency response, interpreter languages, and transportation routes）
may vary depending on the selected plan and schedule.
At our company, we value not only the treatment itself, but also ensuring that you can visit Malaysia with peace of mind, even if it is your first time.
We will tailor the necessary support to your needs without excess or shortage, so please feel free to consult with us.
▼ Support services
・Transportation support
（such as transfers between the airport and hotel, and between the hotel and clinic）
- Private vehicles such as Toyota Alphard are typically arranged.
・Interpreter arrangement
- If explanations are needed in languages other than English, interpreters can be arranged depending on the situation.
・Local point of contact
- We provide a local contact point to assist with questions or unexpected concerns during your stay
(the scope of support may vary depending on the situation).
・Basic lifestyle support
- We also provide information to help make your stay smoother, such as nearby dining options and transportation advice.
▼ Important notes
・Airline tickets and hotel reservations are to be arranged by the client.
・The scope of support
（such as service hours, emergency response, interpreter languages, and transportation routes）
may vary depending on the selected plan and schedule.
At our company, we value not only the treatment itself, but also ensuring that you can visit Malaysia with peace of mind, even if it is your first time.
We will tailor the necessary support to your needs without excess or shortage, so please feel free to consult with us.
I assume there are other clinics in Malaysia offering allogeneic umbilical cord–derived MSC infusions. What makes your company different?
Even when described using the same term, “umbilical cord–derived MSCs,” the actual experience and sense of reassurance can vary greatly depending on where the cells are produced, how they are manufactured, how they are tested, how they are transported, and how the treatment is administered.
Our key difference lies not in exaggerating efficacy, but in our thorough commitment to safety and the reliability of our processes.
1. Partnership with a leading stem cell culturing company and GMP-level management
Our partner places strong emphasis on manufacturing and quality control at a GMP-equivalent level, operating with process management at its core—including procedures, documentation, and shipment release decisions.
GMP is a framework designed to ensure consistency in manufacturing as well as sterile and quality control through structured systems, and it serves as an important benchmark when assessing the reliability of a provider’s operational framework.
2. Joint research and development at a cGMP facility within a national university, supported by clinical trial experience
Our partner also collaborates with affiliated facilities within a national university (UKM) to advance research and development.
UKM has been reported as achieving Malaysia’s first successful clinical trials in stem cell therapy (including for knee osteoarthritis), and public statements have indicated that the university has experience with approved clinical trials.
As a company, we place importance on this type of scientific grounding that integrates both research and clinical experience.
3. Non-cryopreserved (non-frozen) provision
In cell-based products, cryopreservation is sometimes used; however, freezing and thawing processes can affect cellular characteristics, making handling design a critical consideration.
In fact, multiple studies have examined the relationship between cryopreservation and cell properties.
At our company, we create culturing and shipment plans aligned with the treatment schedule and adopt an approach that does not rely on freezing (using refrigerated management instead).
This allows us to provide stem cells in their freshest and most optimal condition, immediately after culturing has been completed.
4. A “low-stress culturing” approach that avoids or minimizes enzymatic burden
In general cell culture processes, enzymes (such as trypsin) may be used during passaging; however, enzymatic treatment has been suggested to affect cell viability and characteristics depending on conditions.
Taking these factors into account, our partner emphasizes culturing designs that minimize unnecessary stress on the cells.
Here again, the objective is not to make definitive claims about efficacy, but rather to reduce sources of variability in cell quality—a philosophy rooted in safety and quality management.
The higher the cell quality, the greater the potential expectations regarding outcomes.
5. Support experience since 2018 and a travel experience designed to meet high-net-worth standards
Since 2018, we have continuously supported primarily Japanese clients, building a support system that minimizes concerns not only in medical aspects, but also in travel, accommodation, and language.
By proactively designing key touchpoints that significantly affect overall satisfaction—such as transportation, interpretation services, and local contact support—we have established the necessary frameworks to provide seamless assistance.
As a result, inquiries from clients outside Japan have increased in recent years.
We have built a system that allows us to provide consistent-quality support to international clients as well, including multilingual assistance, for those traveling from overseas.
Our key difference lies not in exaggerating efficacy, but in our thorough commitment to safety and the reliability of our processes.
1. Partnership with a leading stem cell culturing company and GMP-level management
Our partner places strong emphasis on manufacturing and quality control at a GMP-equivalent level, operating with process management at its core—including procedures, documentation, and shipment release decisions.
GMP is a framework designed to ensure consistency in manufacturing as well as sterile and quality control through structured systems, and it serves as an important benchmark when assessing the reliability of a provider’s operational framework.
2. Joint research and development at a cGMP facility within a national university, supported by clinical trial experience
Our partner also collaborates with affiliated facilities within a national university (UKM) to advance research and development.
UKM has been reported as achieving Malaysia’s first successful clinical trials in stem cell therapy (including for knee osteoarthritis), and public statements have indicated that the university has experience with approved clinical trials.
As a company, we place importance on this type of scientific grounding that integrates both research and clinical experience.
3. Non-cryopreserved (non-frozen) provision
In cell-based products, cryopreservation is sometimes used; however, freezing and thawing processes can affect cellular characteristics, making handling design a critical consideration.
In fact, multiple studies have examined the relationship between cryopreservation and cell properties.
At our company, we create culturing and shipment plans aligned with the treatment schedule and adopt an approach that does not rely on freezing (using refrigerated management instead).
This allows us to provide stem cells in their freshest and most optimal condition, immediately after culturing has been completed.
4. A “low-stress culturing” approach that avoids or minimizes enzymatic burden
In general cell culture processes, enzymes (such as trypsin) may be used during passaging; however, enzymatic treatment has been suggested to affect cell viability and characteristics depending on conditions.
Taking these factors into account, our partner emphasizes culturing designs that minimize unnecessary stress on the cells.
Here again, the objective is not to make definitive claims about efficacy, but rather to reduce sources of variability in cell quality—a philosophy rooted in safety and quality management.
The higher the cell quality, the greater the potential expectations regarding outcomes.
5. Support experience since 2018 and a travel experience designed to meet high-net-worth standards
Since 2018, we have continuously supported primarily Japanese clients, building a support system that minimizes concerns not only in medical aspects, but also in travel, accommodation, and language.
By proactively designing key touchpoints that significantly affect overall satisfaction—such as transportation, interpretation services, and local contact support—we have established the necessary frameworks to provide seamless assistance.
As a result, inquiries from clients outside Japan have increased in recent years.
We have built a system that allows us to provide consistent-quality support to international clients as well, including multilingual assistance, for those traveling from overseas.
